Fundraising FoxLupvindol Biosciences
Sheridan, US · Founded 2024 · Wyoming corporation
Find your way into Lupvindol Biosciences
Sign up to see every warm intro you have to Lupvindol Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lupvindol Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TR
Timothy RogersExecutive ChairmanTimothy Rogers is Executive Chairman of Lupvindol Biosciences, a company developing a steroid-sparing therapeutic platform targeting inflammatory conditions in animals and humans, initially in canine inflammatory bowel disease and equine osteoarthritis. The company has active regulatory engagement with the FDA's Center for Veterinary Medicine and manufacturing-ready formulations.
Reported raises · per SEC filings
Form D private placements$2.2M disclosed across 1 round · 2024
▶$2.2MraisedDec 2024 · 3 investors · BiotechnologyRule 506(b)
▶$2.2MraisedDec 2024 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hunter LandExecutive Officer, Director
- Timothy RogersExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $2.2M
- Minimum investment
- $100K
- Proceeds to insiders
- $75K
- First sale
- Oct 2024
- Incorporated
- Corporation, Wyoming, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Lupvindol Biosciences raised?
- Lupvindol Biosciences has disclosed $2.2M raised across 1 round.
- Where is Lupvindol Biosciences headquartered?
- Lupvindol Biosciences is headquartered in Sheridan, US.